Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck other (Income) Expense Breakdown — Interest Income ($M) ($M)
Form 8-K Supplemental Table 4 (Other (Income) Expense, Net)
Latest, FY2025
-343
Period ended Dec 31, 2025
Change on a year earlier
-17.3%
-415 in FY2024
History
8 years
Since FY2016
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other (Income) Expense Breakdown — Interest Income ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -343 | -17.3% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | -415 | +13.7% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | -365 | +132.5% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | -157 | – | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2019 | Dec 31, 2019 | -274 | -20.1% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2018 | Dec 31, 2018 | -343 | -10.9% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2017 | Dec 31, 2017 | -385 | +17.4% | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
| FY2016 | Dec 31, 2016 | -328 | – | Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗ |
Breakdown
What makes up other (income) expense breakdown — interest income ($m)
- Other (Income) Expense Breakdown — Interest Expense ($M)1,357 · FY2025
- Other (Income) Expense Breakdown — Foreign Exchange Losses ($M)323 · FY2025
- Other (Income) Expense Breakdown — (Income) Loss on Equity Securities, Net ($M)-368 · FY2025
- Other (Income) Expense Breakdown — Net Periodic Defined Benefit Plan (Credit) Cost ($M)-615 · FY2025
- Other (Income) Expense Breakdown — Other, Net ($M)-203 · FY2025
Cite this data
StockData. (2026). Merck Other (Income) Expense Breakdown — Interest Income ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/other_inc_exp_int_inc
See every metric in the Merck KPI table. Data updated Oct 26, 2026.